Francis Medical Announces Further Commercial Expansion of Vanquish® Water Vapor Ablation with First Commercial Procedures to Ablate Targeted Prostate Tissue in the Southeast

Minneapolis, MN [April 16, 2026] – Francis Medical, Inc., a privately held medical device company, today announced the continued expansion of its U.S. commercial launch with the first commercial procedures performed using the Vanquish® Water Vapor Ablation System in the Southeast, a minimally invasive technology designed to ablate targeted prostate tissue. The post Francis Medical Announces Further Commercial Expansion of Vanquish ® Water Vapor Ablation with First Commercial Procedures to Ablate Targeted Prostate Tissue in the Southeast appeared first on Francis Medical .